Medicaid Provider

Back to Topic Index

Administrative Salaries
Management fees paid to an individual who is not actively engaged in the day-to-day activities of a nursing home are not a cost of doing business, nor are they an expense related to the conduct of nursing home activities. Decision: 8 N.J.A.R. 463
Denial of Reimbursement
A Medicaid provider is not entitled to a hearing prior to a denial of reimbursement. Decision: 3 N.J.A.R. 351
When no agency policy exists either authorizing or precluding a Medicaid provider from performing a service and it does so at the request of a physician it should receive payment for the labor involved. Decision: 4 N.J.A.R. 278
Hospital Reimbursement
A hospital's failure to sustain its burden of proof to demonstrate additional costs for policy finance benefit costs, fiscal costs and plant costs results in a denial of change in established Blue Cross reimbursement rates. Decision: 4 N.J.A.R. 076
Impact Increment
In a proceeding to recoup excess impact increments, a Medicaid provider should be able to set off against the claim of the Division of Medical Assistance any valid claim for impact increments it may have. Decision: 1 N.J.A.R. 240
Notice
A series of letters to a hospital constitutes sufficient notice that it was being denied Medicaid reimbursement. Decision: 3 N.J.A.R. 351
Overpayments
Recovery of Medicaid overpayments with interests will not be barred by equitable estoppel where no showing was made that an officer of the State, conscious of the State's true interest and aware of petitioner's misapprehension stood by while the other party acted in detrimental reliance. Decision: 8 N.J.A.R. 217
Interest on unintentional overpayments from the Division of Medical Assistance and Health Services accrues from the date the overpayment was made and continues until it is repaid. Decision: 8 N.J.A.R. 195
Interest payments on Medical Assistance overpayments are tolled in the event the State does not give the provider notice of such overpayments within 180 days of a filed audit. Decision: 8 N.J.A.R. 195
Personal Liability
While New Jersey law will not permit the piercing of a corporate veil in the absence of fraud or injustice, Federal case law governs the administration of Federal programs and will allow the piercing of a corporate veil to present circumvention of a statute or advoidance of a clear legislative purpose. Decision: 8 N.J.A.R. 217
Rate Setting
The rate setting procedures for the establishment of Medicaid reimbursement rates are entitled to a presumption of reasonability; a presumption which is not overcome when no specific expert testimony on the question is presented. Decision: 8 N.J.A.R. 231
The rate setting methodology used by the Division of Medical Assistance and Health Services is entitled to a presumption of reasonableness and it is the provider which bears the burden to demonstrate otherwise. Decision: 8 N.J.A.R. 561
Increasing utility costs do not constitute an unusual situation under N.J.A.C. 10:63-3.20 and thus would not support a change in Medicaid rate setting guidelines. Decision: 8 N.J.A.R. 475
The Division of Medical Assistance and Health Services, and not the Department of Health, is alone responsible for the validity of Medicaid rates. Decision: 8 N.J.A.R. 389
The Division of Medical Assistance and Health Services is not bound by a recommendation by the Department of Health to revise Medicaid reimbursement rates since the Department's statutory role is limited to assisting the Division with the development of reimbursement rates. Decision: 8 N.J.A.R. 389
Suspension
Authority to suspend Medicaid status on grounds of moral turpitude requires the prior approval of the Attorney General. Decision: 5 N.J.A.R. 430
N.J.S.A. 30:4D-11.1(a) vests the Division of Medical Assistance and Health Services with the authority to suspend persons from participating in Medicaid independent of any licensing board. Decision: 8 N.J.A.R. 517
Unusual Costs
Increasing utility costs do not constitute an unusual situation under N.J.A.C. 10:63-3.20 and thus would not support a change in Medicaid rate setting guidelines. Decision: 8 N.J.A.R. 475